Equities
  • Price (USD)429.30
  • Today's Change-6.45 / -1.48%
  • Shares traded3.00
  • 1 Year change+9.87%
  • Beta--
Data delayed at least 20 minutes, as of Jul 30 2021 19:00 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Humana Inc. is a health and well-being company. The Company's segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, including dental, vision, and other supplemental health and financial protection products. The Healthcare Services segment includes services offered to its health plan members, as well as to third parties, including pharmacy solutions, provider services, home-based services and clinical programs, as well as services and capabilities to manage population health. The Individual Commercial segment includes Individual Commercial products marketed under the HumanaOne brand.

  • Revenue in USD (TTM)80.45bn
  • Net income in USD2.48bn
  • Incorporated1964
  • Employees48.70k
  • Location
    Humana Inc500 W Main StLOUISVILLE 40202United StatesUSA
  • Phone+1 (502) 580-1000
  • Fax+1 (302) 636-5454
  • Websitehttp://www.humana.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
HUM:NYQ since
announced
Transaction
value
One Homecare Solutions LLCAnnounced14 Jun 202114 Jun 2021Announced1.59%--
Kindred at Home IncAnnounced27 Apr 202127 Apr 2021Announced-4.55%5.70bn
Data delayed at least 15 minutes, as of Jul 30 2021 21:10 BST.
Refinitiv, an LSEG business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.